Economic impact of biofilms on treatment costs

Biofilms, Infection, and Antimicrobial Therapy

Volumn , Issue , 2005, Pages 21-38

  Thomas, John G ^a   Litton, Isaiah ^b   Rinde, Harald ^c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c BioMedical Strategies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 39649112261     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (31)

1. Costerton, J.W., Lewandowski, Z., Caldwell, D.E., Korber, D.R., and Lappin-Scott, H.M., Microbial biofilms. Annu. Rev. Microbiol. 49, 711-745, 1995.
2. Costerton, J.W., Stewart, P.S., and Greenberg, E.P., Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322, 1999.
3. Donlan, R.M., Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 33, 1387-1392, 2001.
4. Donlan, R.M., Biofilms and device-associated infections. Emerg. Infect. Dis. 7, 277-281, 2001.
5. Donlan, R.M., and Costerton, J.W., Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193, 2002.
6. Hall-Stoodley, L., Costerton, J.W., and Stoodley, P., Bacterial biofilms: from the natural environment to infectious diseases. Mature Reviews Microbiology 2, 95-108, 2004.
7. Fux, C.A., Stoodley, P., Hall-Stoodley, L., and Costerton, W.J., Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti-Infect. Ther. 1 (4), 667-683, 2003.
8. Ceri, H., Olson, M.E., Stremick, C., Read, R.R., Morck, D., and Buret, A., The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37, 1771-1776, 1999.
9. Habash, M., and Reid, G., Microbial biofilms: their development and significance for medical device-related infections. J. Clin. Pharmacol. 39, 887-898, 1999.
10. Hanna, H.A., Radd, I.I., Hackett, B., Wallace, S.K., Price, K.J., Coyle, D.E., and Parmley, C.L., Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in criticall ill patients. Chest 124, 10030-11038, 2003.
11. Mermel, L.A., Farr, B.M., Sherertz, R.J., Raad, I.I., O’Grady, N., Harris, J.S., and Craven, D.E., Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32, 1249-1272, 2001.
12. O’Grady, N.P., Alexander, M., Dellinger, E.P., Gerberding, J.L., Heard, S.O., Maki, D.G., Masur, H., McCormick, R.D., Mermel, L.A., Pearson, M.L., Raad, I.I., Randolph, A., and Weinstein, R.A., Guidelines for the prevention of intravascular catheterrelated infections. Infect. Control Hosp. Epidemiol. 23, 759-769, 2002.
13. Raad, I.I., Vascular catheters impregnated with antimicrobial agents: present knowledge and future direction. Infect. Control Hosp. Epidemiol. 18 (4), 1-5, 1999.
14. Ryder, M., Peripheral access options. Surgical Oncology Clinical of North America, 4 (3), 395-427, 1995.
15. Ryder, M., Peripherally inserted central venous catheters. Nursing Clinical of North America, 28, 937-992, 1993.
16. Weinstein, R.A., MD Adding insult to injury: device-related infections. Infectious Diseases Conference Summaries - 2000, Medscape, Inc., 2000.
17. Ryder, M., The role of biofilm in vascular catheter-related infections. New Dev. Vasc. Dis. 2 (2), 15-25, 2001.
18. Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T., and Ghannoum, M.A., Biofilm formation by the fungal pathogen Candida albicans, development, architecture, and drug resistance. J. Bacteriol. 183, 5385, 2001.
19. Kuhn, D.M., Chandra, J., Mukherjee, P.K., and Ghannoum, M.A., Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70, 878-888, 2002.
20. Murga, R., et al., Biofilm formation by Gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J. Clin. Microbiol. 39, 2294-2297, 2001.
21. CDC. Seven healthcare safety challenges. 2000.
22. Tighe, M.J., Kite, P., Thomas, D., et al., Rapid diagnosis of catheter-related sepsis using the acridine orange cytospin test and an endoluminal brush. J. Nutr. 20, 215-218, 1996.
23. Kite, P., Tighe, M.J., Thomas, D., et al., Gram/acridine orange leucocyte cytospin (G/AOLC) rapid method rapid diagnosis of catheter related sepsis using the acridine orange leucocyte cytpspin test and an endoluminal brush. J. Parenteral. Nutr. 3, 215-218, 1996.
24. Ceri, H., Olson, M.E., Stremick, C., Read, R.R., Morck, D., and Buret, A., The Calgary Biofilm Device, new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37, 1771-1776, 1999.
25. Donabedian, A., The role of outcomes in quality assessment and assurance. QRB Qual. Rev. Bull. 18, 356-360, 1992.
26. Donabedian, A., The effectiveness of quality assurance. Int. J. Qual. Health Care 8, 401-407, 1996.
27. Adair, C.G., Gorman, S.P., Feron, B.M., Byers, L.M., Jones, D.S., Goldsmith, C.E., Moore, J.E., Kerr, J.R., Curran, M.D., Hogg, G., Webb, C.H., McCarthy, G.J., and Milligan, K.R., Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 25, 1072-1076, 1999.
28. Wilson, L.S., Reyes, C.M., Stolpman, M., Speckman, J., Allen, K., and Beney, J., The direct cost and incidence of systemic fungal infections. Value Health 5, 26-34, 2002.
29. O’Grady, N.P., et al., and working group, Guidelines for the Prevention of Intravascular Catheter-Related Infections. J. Infusion Nursing 25 (65), S37-S64, 2002.
30. Raad, I., Intravascular-catheter-related infections. Lancet 351, 893-899, 1998.
31. Siegman-Izra, Y., Anglim, A.M., Shapiro, D.E., et al., Diagnosis of catheter-related bloodstream infection: A meta-analysis. J. Clin. Microbiol. 35, 928-936, 1997.